Your Article Summary
See Latest ArticlesIs the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia
European Journal of Haematology, 06/18/09
Song MK et al. - A high response rate was associated with a short interval between diagnosis and initiation of IST as well as high CsA levels during the first and second week of IST. Therefore, early intensification of CsA levels might improve patient outcome.
Related Articles
Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia
International Journal of Hematology, 10/23/09
Relevance Score: 69%
Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMT
Bone Marrow Transplantation, 11/19/09
Relevance Score: 67%
Aplastic anemia in the orient
International Journal of Hematology, 10/07/09
Relevance Score: 67%
New advances in the treatment of acquired severe aplastic anaemia
International Journal of Hematology, 10/07/09
Relevance Score: 67%
The relationship of aplastic anemia and PNH
International Journal of Hematology, 10/07/09
Relevance Score: 67%
Today in Anemia/Polycythemia...keeping you current
Receive free subspecialty "5-minute updates" via email
Diabetes mellitus is associated with high early-mortality and poor prognosis in patients with autoimmune hemolytic anemia
Hematology, 12/03/09
The expanding spectrum of thalassemia intermedia
Hematology, 12/03/09
Reference percentiles of hematological and biochemical iron values of blood donors in Port Harcourt, Nigeria
Hematology, 12/03/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Melphalan 200 mg/m2 versus Melphalan 100 mg/m2 in newly diagnosed myeloma patients: A prospective, multi-center phase III study
Blood, 12/03/09
A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumors
Cancer Chemotherapy and Pharmacology, 12/03/09
Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody
British Journal of Cancer, 12/03/09